Bevacizumab and gastrointestinal perforations: A review from the FDA Adverse Event Reporting System (FAERS) database

Sufyan AbdulMujeeb; Thomas Wichelmann; Eli Ehrenpreis

doi:10.1111/apt.16601

Bevacizumab and gastrointestinal perforations: A review from the FDA Adverse Event Reporting System (FAERS) database

Sufyan AbdulMujeeb, Thomas Wichelmann, Eli Ehrenpreis

Advocate Aurora Health

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Alimentary pharmacology & therapeutics
DOIs	https://doi.org/10.1111/apt.16601
Status	Published - Sep 9 2021

Access to Document

10.1111/apt.16601License: Unspecified

Cite this

@article{6aa0f94d007d4e37b92ef15bd425228d,

title = "Bevacizumab and gastrointestinal perforations: A review from the FDA Adverse Event Reporting System (FAERS) database",

author = "Sufyan AbdulMujeeb and Thomas Wichelmann and Eli Ehrenpreis",

note = "Wichelmann TA, Abdulmujeeb S, Ehrenpreis ED. Bevacizumab and gastrointestinal perforations: a review from the FDA Adverse Event Reporting System (Faers) database. Aliment Pharmacol Ther. 2021;54(10):1290-1297. doi: 10.1111/apt.16601",

year = "2021",

month = sep,

day = "9",

doi = "10.1111/apt.16601",

language = "American English",

journal = "Alimentary pharmacology & therapeutics",

}

TY - JOUR

T1 - Bevacizumab and gastrointestinal perforations: A review from the FDA Adverse Event Reporting System (FAERS) database

AU - AbdulMujeeb, Sufyan

AU - Wichelmann, Thomas

AU - Ehrenpreis, Eli

N1 - Wichelmann TA, Abdulmujeeb S, Ehrenpreis ED. Bevacizumab and gastrointestinal perforations: a review from the FDA Adverse Event Reporting System (Faers) database. Aliment Pharmacol Ther. 2021;54(10):1290-1297. doi: 10.1111/apt.16601

PY - 2021/9/9

Y1 - 2021/9/9

UR - https://institutionalrepository.aah.org/alghintmedresidents/38

UR - https://xk8bg6rv9a.search.serialssolutions.com/?sid=Entrez:PubMed&id=pmid:34499740

U2 - 10.1111/apt.16601

DO - 10.1111/apt.16601

M3 - Article

JO - Alimentary pharmacology & therapeutics

JF - Alimentary pharmacology & therapeutics

ER -

Bevacizumab and gastrointestinal perforations: A review from the FDA Adverse Event Reporting System (FAERS) database

Access to Document

Other files and links

Cite this